Radiology Business
SEPTEMBER 20, 2023
Backers include societies representing radiologists and nuclear medicine professionals, device manufacturers, patient advocacy groups, and pharmaceutical companies.
AuntMinnie
JULY 12, 2024
As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Image courtesy of Washington University. "We Nuclear Regulatory Commission and is an integral part of a theranostics practice.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Open Medscience
JANUARY 12, 2024
Radiopharmaceuticals, combining radioactive and pharmaceutical elements, enable precise diagnosis and treatment in nuclear medicine. The post The Transformative Impact of Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.
Imaging Technology
JULY 9, 2024
Marco Campione brings more than 25 years of experience from GE HealthCare, where he most recently served as Executive Director and Global Head of Contrast Media, General Manager Pharmaceutical Diagnostics North America and President GE HealthCare Inc., Blue Earth Diagnostics, an indirect subsidiary of Bracco Imaging S.p.A.,
AuntMinnie
JUNE 10, 2024
Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He completed a postdoctoral fellowship in molecular imaging at Memorial Sloan Kettering Cancer Center. He will be honored at the SNMMI's annual meeting in Toronto.
Imaging Technology
JUNE 15, 2023
The study will also then help identify early response to immunotherapies, using sequential whole-body imaging to monitor CD8 changes over time, enabling physicians to switch patients who are not responding to alternative treatment options sooner. For more information: www.gehealthcare.com References: Shankar L.
Imaging Technology
MAY 25, 2023
is the only FDA approved FES PET imaging agent. Cerianna is indicated for use with PET imaging for the detection of ER+ lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer. GE HealthCare’s Cerianna , available in the U.S., J Nucl Med. 2011;52(10):1541-1549 / Currin, et al. J Natl Compr Canc Netw.
Expert insights. Personalized for you.
101 
Let's personalize your content